Bio-art and bio-design as economic activity

Bio-art and bio-design as economic activity covers gallery- and museum-commissioned design work built around living or biologically-derived materials — most visibly grown mycelium and other biofabricated materials shaped into art objects and design pieces — as economic activity distinct from the functional bio-material product companies (packaging, leather alternatives, construction materials) already covered elsewhere on this site. This is a genuinely thin commercial category: bio-art as gallery/exhibition economic activity is dominated by individual artists and grant- or academic-funded studios (university design labs, educational competitions) rather than a broad commercial vendor market with product pages. As of 2026 only one studio was confirmed with strong, on-topic, museum-exhibition-level evidence of ongoing commissioned bio-design work.

The key directions of bio-art and bio-design as economic activity are:

1. 3D-printed living-material design: using 3D printing techniques to shape living materials like mycelium into finished design or art objects, a genuine technical innovation distinct from conventional biofabrication molding.
2. Museum and gallery commissions: design work commissioned specifically for exhibition in museums and galleries, generating revenue through commission fees and exhibition licensing rather than product sales.
3. Materials-innovation design practice: a design practice organized around pioneering new biological material applications, positioning the studio’s work at the intersection of art, design, and materials science.
4. Grant/academic-funded bio-design: the broader field’s dominant funding model — university design labs and educational competitions (e.g. the Biodesign Challenge) rather than commercial commissions.

Sectoral value chain#

[Material innovation R&D] ──> [Design/artwork creation] ──> [Gallery/museum commission] ──> [Exhibition installation]
                                                                        │
                                                              (public/critical reception)
                                                                        │
                                                                        ▼
[Commission revenue/licensing] <─── [Exhibition run] <────────────────┘

Value chain levels#

Cross-cutting technologies of the sector:

• 3D printing of living materials: printing techniques adapted to shape mycelium or other living biological substrates into precise design geometries.
• Biofabrication for design (not function): materials science applied to aesthetic and conceptual design objects rather than functional commercial products.
• Museum/gallery commissioning practice: the institutional and commercial mechanics of art/design commissioning, distinct from product manufacturing and sale.

The category’s core innovation is technical fabrication method applied to artistic and design ends rather than commercial product function.

1. 3D-printed mycelium fabrication:
   • Studio Klarenbeek & Dros pioneered 3D-printing mycelium, a living, thread-like fungal root structure, into precise design geometries — a genuine materials-science first credited to the studio by a major museum.
2. Museum-exhibition-scale commissioning:
   • The studio’s work being commissioned for a dedicated Pinakothek der Moderne exhibition reflects the commission-and-exhibition economic model that defines this category, distinct from product manufacturing.
3. Materials-innovation positioning:
   • The studio’s practice is explicitly framed around materials innovation rather than conventional design aesthetics, positioning its bio-design work at the intersection of art, design, and applied materials science.